FDA Center for Drug Evaluation & Research Issues Warning Letter to Maximus
June 17, 2026
June 17, 2026
WASHINGTON, June 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Maximus Health Inc. dba Maximus from its Center for Drug Evaluation and Research:
* * *
Recipient: Maximus Health, Inc. dba Maximus, 2219 Main Street, #347, Santa Monica, CA 90405, United States, hello@maximustribe.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LE . . .
* * *
Recipient: Maximus Health, Inc. dba Maximus, 2219 Main Street, #347, Santa Monica, CA 90405, United States, hello@maximustribe.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LE . . .